Antibiotics from Extremophilic Micromycetes.

Area of Science:

• Microbiology
• Natural Product Chemistry
• Biotechnology

Background:

• Extremophilic microorganisms thrive in extreme environments.
• Their enzymes (extremozymes) have industrial applications.
• The potential of extremophiles as sources of novel bioactive compounds remains largely untapped.

Purpose of the Study:

• To review recent findings on antibiotic compounds from extremophilic micromycetes.
• To classify these metabolites by structure and biosynthetic origin.
• To summarize their biological activities.

Main Methods:

• Literature review of studies published in 2018-2019.
• Classification of secondary metabolites based on chemical structure.
• Analysis of biosynthetic pathways.
• Compilation of data on biological activities.

Main Results:

• Extremophilic micromycetes produce diverse secondary metabolites with antibiotic properties.
• These compounds exhibit potential against antibiotic-resistant pathogens.
• Novel structural scaffolds and mechanisms of action are being discovered.

Conclusions:

• Extremophilic micromycetes represent a valuable resource for discovering new antibiotics.
• Further research can yield compounds to address the global challenge of antimicrobial resistance.
• These findings support the exploration of extreme environments for drug discovery.